Potassium Chloride Injection, Solution
Product Images NDC 0990-7074

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 0990-7074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Icu Medical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (100 mL Bag Label)

Principal Display Panel (100 mL Bag Label)
This text describes a medical product- Potassium Chloride Injection. It is highly concentrated at 100 mEq/L and is intended for use with a calibrated infusion device. The solution is supplied in a single-dose container of 100 mL with the identifier NDC 0990-7074-26. The solution contains DEHP and its composition, including electrolytes, is mentioned in detail. The recommended dosage, cautionary instructions, and usage guide for the product can be found in the insert provided along with the container. The manufacturer of the product is ICU Medical, Inc. based in Lake Forest, Illinois.*
FDA Label Image

Principal Display Panel (100 mL Bag Pouch Label)

Principal Display Panel (100 mL Bag Pouch Label)
This is a description of a medication called POTASSIUM CHLORIDE Inj. It is a highly concentrated solution that is used with a calibrated infusion device. Each 100 mL contains potassium chloride 745 mg in water for injection. The electrolytes per 1000 mL are potassium 100 mEq and chloride 100 mEq. It is a single-dose container meant for LV use, and the usual dosage should be checked in the insert. The overwrap is a moisture barrier that protects the solution when stored at 20 to 25°C (88 77°F) and should be removed when ready to use. It should not be used in series connections, and sterile, non-pyrogenic conditions should be maintained. If a leak is found, the unit should be discarded. ICU Medical, Inc. located in Illinois, USA manufactures the medication.*
FDA Label Image

Principal Display Panel (50 mL Bag Label)

Principal Display Panel (50 mL Bag Label)
This is a highly concentrated POTASSIUM CHLORIDE injection that is intended for use with a calibrated infusion device. Each 100 mL contains 1490 mg of potassium chloride and is formulated in water for injection. The solution has a pH range of 5.8 and an osmolality of 400 mOsmol/LITER. It is recommended to use the central route whenever possible, and this is a single-dose container. The usual dosage is provided in the insert. The solution should only be used if it is clear and undamaged, and it must not be used in series connections.*
FDA Label Image

Principal Display Panel (50 mL Bag Pouch Label)

Principal Display Panel (50 mL Bag Pouch Label)
This is a single-dose container of highly concentrated Potassium Chloride Injection, for use with a calibrated infusion device. Each 50 ml contains 200 mEq/L of potassium chloride in water for injection. The electralytes per 1000 mL are 200 mEq of potassium and 200 mEq of chloride. It is a sterile, nonpyrogenic solution, intended for use as a LV. It is recommended to not add supplementary medication, and always use the central route whenever possible. The overwrap is a moisture barrier, and the unit must not be removed from overwrap until ready to be used. Store at 20 to 25°C (68 to 77°F) and protect from freezing.*
FDA Label Image

Principal Display Panel (50 mL Bag Label)

Principal Display Panel (50 mL Bag Label)
This is a description of a Potassium Chloride injection solution containing 400mEq/50mL in water for injection. It is designed for intravenous use and must only be used with a calibrated infusion device. The solution should not be added with any supplementary medication, and the manufacturer recommends using the central route to administer the solution. It is a sterile, non-pyrogenic and hypertonic solution, therefore, it may cause vein damage. The container must not be used in the series connection, and the dosage recommendations are mentioned in the insert. The solution is packaged in a single-dose container and must be used if the solution is clear and the container is undamaged. The company providing this injection is ICU Medical Inc.*
FDA Label Image

Principal Display Panel (50 mL Bag Pouch Label)

Principal Display Panel (50 mL Bag Pouch Label)
This is a product description for K3, a highly concentrated Potassium Chloride injection solution that should only be used with a calibrated infusion device. It comes in a single-dose container and contains 1.49g of Potassium Chloride per 50mL in water for injection. It is indicated for electrolyte replacement therapy and should be used only when the solution is clear, while the overwrap should not be removed until ready for use. K3 is hypertonic and may cause vein damage; therefore, it should not be used in series connections. The solution requires careful use because it should not be added with any supplementary medication, and discontinuation must be observed if an adverse reaction occurs. Instructions for use and dosing may be found in the insert.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.